Cedar Brook Financial Partners, LLC Royalty Pharma PLC Transaction History

Cedar Brook Financial Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $187,650 - $221,100	5,000 New	5,000 $210,000
Q3 2021 Nov 01, 2021	SELL	$36.14 - $42.24 $180,700 - $211,200	-5,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $180,600 - $250,250	5,000 New	5,000 $250,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.